Abstracts
Janssen, B. J. C., Halff, E., Lambris, J. D. Gros, P.
(2007).
Structure of C3c in complex with compstatin reveals a new mechanism of complement inhibition.
Molecular Immunology
44(16):3930.
|
||
Katragadda, M., Sfyroera, G., Paola, M.Janssen, B. J. C. Gros, P.and Lambris, J. D.
(2007).
Structure-activity-based design of potent compstatin analogs.
Molecular Immunology
44(1-3):192.
|
||
Lambris, J. D., Sfyoera, G., Hammel, M.Ricklin, D. Magotti, P. Geisbrecht, B. V.
(2007).
A novel complement evasion mechanism of Staphylococcus aureus using Efb.
Molecular Immunology
44(16):3926.
|
||
Lambris, J. D., Sfyroera, G., Schuster, M. Chen, H.Tzekou, A.Papp, K.Winters, M. Woods, V. L.
(2007).
Studies on the solvent accessibility of native C3 and its fragments, as analyzed by HDX-MS.
Molecular Immunology
44(1-3):202.
|
||
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D.
(2007).
Complement - A regulator of pro-survival pathways in liver regeneration.
Molecular Immunology
44(1-3): 213-214.
|
||
Ricklin, D. Sfyoera, G., Hammel, M.Magotti, P. Geisbrecht, B. V. Lambris, J. D
.
(2007).
Combining Forces against Bacterial Infections - Using SPR, ITC, Biochemical and Structural Data to Describe a Novel Complement Evasion Mechanism of Staphylococcus Aureus.
DIPIA
|
||
Ricklin, D. Sfyoera, G., Hammel, M.Magotti, P. Geisbrecht, B. V. Lambris, J. D.
(2007).
Molecular Interactions of Efb: Describing a Novel Complement Evasion Mechanism of Staphylococcus Aureus.
21st Annual Symposium of The Protein Society, Boston
|
||
Ritis, K. Doumas, M.Mastellos, D. Micheli, A. Giaglis, S. Magotti, P. Farail, S.Kartalis, G. Sideras, P. Lambris, J. D.
(2007).
A novel C5aR-tissue factor crosstalk in neutrophils links innate immunity to coagulation pathways.
Molecular Immunology
44(1-3):266.
|
||
Sarma, V. Huber-Lang, M. Zetoune, F. S. Rittirsch, D. Lambris, J. D. Drouin, S. M. Wetsel, R. A. Ward, P. A.
(2007).
Generation of C5a in the absence of C3: A new complement activation pathway.
Molecular Immunology
44(1-3):235.
|
||
Sfyroera, G. Melillo, D. De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R.
(2007).
First identification of a chemotactic receptor in an invertebrate species: Structural and functional characterization of Ciona intestinalis C3a receptor.
Molecular Immunology
44(1-3): 238-239.
|
||
Sfyroera, G. Melillo, D. De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R.
(2007).
First identification of a chemotactic receptor in an invertebrate species: Structural and functional characterization of Ciona intestinalis C3a receptor.
Molecular Immunology
44(1-3): 238-239.
|
||
Thurman,J.M., Lenderink,A.M., Royer,P.A., Zhou,J., Lambris,J.D., Nemenoff,R.A., Quigg,R.J. and Holers,V.M.
(2007).
Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines.
Molecular Immunology
44 (1-3):250.
|
||
Tjernberg, J., Lindblom, S., Ekdahl, K. N. Lambris, J. Korsgren, O. Nilsson, B.
(2007).
Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation.
Xenotransplantation
14(5):454.
|
||
Waage, C. Nielsen, E. W. Fure, H.Brekke, O. L. Sfyoera, G. Lambris, J. D. Mollnes, T. E.
(2007).
Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Molecular Immunology
44(1-3):254.
|
||
Zhang, X. H. Kimura, Y., Fang, C. Y. Zhou, L.Sfyroera, G. Lambris, J. D. Wetsel, R. A. Miwa, T.and Song, W. C.
(2007).
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.
Molecular Immunology
44 (1-3):263.
|
||
Engberg, A. E., Lambris, J. D., Nilsson, B. Nilsson-Ekdahl, K.
(2006).
Mass Spectrometric indentification of proteins that binding to biomaterial surfaces. Evidence for covalent binding of C3 to surfcae bound proteins.
4rth, International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:85.
|
||
Hamad, A. Lambris, J. D. Nilsson-Ekdahl, K. Nilsson, B.
(2006).
Complement activation induced by thrombin receptor-activated platelets.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:87.
|
||
Lambris, J. D.
(2006).
Protein-protein interactions in the complement system and development of compement therapeutics.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:60.
|
||
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D.
(2006).
Complement - a regulator of pro-survival pathways in liver regeneration.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:37.
|
||
Melillo, D. Sfyoera, G., De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R.
(2006).
First indentification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:41.
|
||
Stevens, B. Christopherson, K. S. Huberman, A. D. Lambris, J. D. Barres, B. A.
(2006).
The complement cascade mediates developmental synapse elimination.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:38.
|
||
Thurman, J. M., Lenderink, A. M.Royer, P. A. Zhou, J.Lambris, J. D. Nemenoff, R. A. Quigg, R. J. Holers, M.
(2006).
Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines.
XXI ICW.Beijing, China, Molucular Immunology
44(1-3):250.
|
||
Zetoune, F. S., Huberman, A. D.Sarma, V.Rittirsch, D. Lambris, J. D. Ward, P.
(2006).
C5a gemeration in the absence of C3.
4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences
23:43.
|
||
Zetoune,F.S., Sarma,J.V., Rittirsch,D., Lambris,J.D., McGuire,S.R. and Ward,P.A.
(2006).
Thrombin as a C5 convertase.
Faseb Journal
20(4):A641.
|
||
Bergseth,G., Lappegard,K.T., Lambris,J.D., Fure,H. and Mollnes,T.E.
(2006).
Complement-dependent chemokine synthesis induced by an artificial surface: role of leukocyte subpopulations.
Molecular Immunology
43(1-2):171-172.
|
||
Lambris, J. D.
(2006).
A "multidisciplinary" approach to understand disease pathogenesis and develp therapeutics.
4rth International Conference on Pathways, Networks and Systems: Theory and Experiments, Mykonos, Greece, Aegean Conferences
27:44.
|
||
Kohl, J. Balder, R.Lewkowich, I. Pandey, M. K Hawlisch, H. Wang, L.Herman, N.Sproles, A. Best, J.Zwirner, J. Whitsett, J. D. Lambris, J. D. Wills-Karp, M.
(2005).
A regulatory role for the C5a anaphylatoxin on type 2 immunity in asthma.
3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences
18:35.
|
||
Kohl, J. Balder, R.Lewkowich, I. Pandey, M. K Hawlisch, H. Wang, L.Herman, N.Sproles, A. Best, J.Zwirner, J. Whitsett, J. D. Lambris, J. D. Wills-Karp, M.
(2005).
A regulatory role for the C5a anaphylatoxin on type 2 immunity in experimental asthma.
10th European Meeting on Complement in Human DiseaseHeidelberg, Germany
|
||
Lambris, J. D.
(2005).
Intergrating innate immunity into a "systems context"; the complement paradigm.
Crossroads between innate and Adaptive Immunity. Rhodes, Greece, Aegean Conferences
21:30.
|
||
Lambris, J. D.
(2005).
Intergrating innate immunity into a "systems context"; the complement paradigm.
3rd International Conference on Pathways, Networks and Systems: Theory and Experiments. Rhodes, Greece, Aegean Conferences2
0:28.
|
||
Lambris, J. D.
(2005).
A "multidisciplinary" approach to today's challenges in biosciences.
13th Signal and Signal Processing in the Immune System.EFIS ConferenceBalatonoszod, Hungary, September
|
||
Lambris, J. D.
(2005).
From atoms to systems: A "multidisciplinary approach to today's challenges in biosciences.
3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences
18:34.
|
||
Lambris, J. D.
(2005).
A "multidisciplinary" approach to today's challenges in biosciences.
2nd International Conference on Tissue Enginnering, Crete, Greece, Aegean Conferences
16:88.
|
||
Lambris, J. D.
(2005).
A "multidisciplinary" approach to today's challenges in biosciences.
3rd Workshop on Lymphocyte Signal Transduction, Crete, Greece, Aegean Conferences
17:63.
|
||
Madhavan, M. C., Tsonis, P. A., Lambris, J. D. Del Rio-Tsonis, K.
(2005).
A role of complement components in regeneration.
3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences
18:24.
|
||
Mocco, J. Mack, W. J. Botto, M.Holland, M. C. H. Lambris, J. D. Pinsky, D. J. Connolly, E. S.
(2005).
Aggressive reduction of C3 is critical to alleviating complement mediated injury following cerebral ischemia/reperfusion.
3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences
18:29.
|
||
Reca, R. Lambris, J. D., Ross, G. D. Ratajczak, M.
(2005).
Transplantation studies in C3-deficient animals reveal a novel role of third complement component(C3) in engrament/regeneration of bone marrow.
3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences
18:25.
|
||
Fabry, Z. Nacewicz, B. Liu, F.Sewell, D.Macvilay, S. Erdei, A.Lambris, J. D. Sandor, M.
(2004).
Role of complement in acute traumatic brain injury.
Molecular Immunology
41(2-3):227.
|
||
Lambris, J. D.
(2004).
From Atoms to Systems: A "Multidisciplinary" Approach to Innate Immunity.
3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences
13:63.
|
||
Lambris, J. D., Katragadda, M., Spruce, L.and Morikis, D.
(2004).
The compstatin case: an UPDATE, on its structure and functions.
Molecular Immunology
41(2-3):265.
|
||
Mallik,B., Lambris,J.D. and Morikis,D.
(2004).
Rational design of a potent inhibitor for unregulated complement activation using molecular dynamics simulations and nuclear magnetic resonance data.
Abstracts of Papers of the American Chemical Society
227:U908-U909.
|
||
Markiewski, M. M., Mastellos, D., Tudoran, R. Strey, C. W. DeAngelis, R. A. Franchini, S. Wetsel, R. A. Erdei, A.and Lambris, J. D.
(2004).
The role of complement in liver regeneration: both C3a and are critical for normal liver recovery after toxic injury.
Molecular Immunology
41(2-3):273.
|
||
Morikis, D. Mallik, B.and Lambris, J. D.
(2004).
NMR and molecular simulations as tools for characterization of compastatin and active hybrid peptide-peptidomimetic analogs.
Molecular Immunology
41:281-282.
|
||
Morikis,D. and Lambris,J.D.
(2004).
Electrostatics drive C3D-CR2 association.
Abstracts of Papers of the American Chemical Society
227:U913.
|
||
Sandor, M. Lambris, J. D. Suresh, M.
(2004).
Complement Regulates T Cell Responses.
3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences
13:37.
|
||
Sfyroera, G. Isaacs, S. N. Katragadda, M. Lambris, J. D.
(2004).
Structural-functional analysis of VCP and SPICE interactions with C3b.
Molecular Immunology
41(2-3): 305-306.
|
||
Winters,M.S., Spellman,D.S. and Lambris,J.D.
(2004).
Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry.
Protein Science
13 :102-103.
|
||
Yamada, K. Miwa, T.Liu, J.Nangaku, M. Lambris, J. D. Song, W. C.
(2004).
Critical protection from renal ischemia reperfusion injury by DAF and CD59.
Molecular Immunology
41(2-3): 328-329.
|
||
Allendorf, D. J., Baran, J. T., Hansen, R. D. Subbarao, K. Walsh, D.Hong, F.Marroquin, J. Yan, J.Lambris, J. D. Haribabu, B. Ross, G. D.
(2003).
Orally administered beta-glucan functions via anti-tumor mAbs and the complement system to recruit CR3(+) neutrophils and macrophages that produce tumor regression and tumor-free survival.
Molecular Immunology
40(2-4): 195-196.
|
||
Blatteis, C. M., Li, S. X., ballou, L. R. Boackle, S. A. Holers, M.and Lambris, J. D.
(2003).
Complement and the pathogenesis of endotoxic fever.
2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences
9:59.
|
||
Girardi, G. Berman, J.Hollmann, T. Lambris, J. D. Wetsel, R. A. Holers, M.and Salmon, J. E.
(2003).
C5a-C5aR interactions and recruitment of PMN mediate antiphospholipid antibody(aPL)-induced pregnancy loss in mice.
2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences
9:54.
|
||
Girardi, G. Berman, J.Tudoran, R. Chinnici, C. Erdei, A.Lambris, J. Salmon, J.
(2003).
A potential mechanism for therapeutic efficacy for heparin in antiphospholipid-induced pregnancyloss-inhibition of complement.
Arthritis and Rheumatism
48(9):S163.
|
||
Lambris, J. D., Del Rio-Tsonis, K.Franchini, S. Kimura, Y.Markiewski, M. M. Mastellos, D. Strey, C. W. Tsonis, P. A.
(2003).
The role of complement in developmental processes.
2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences
9:52.
|
||
Li, S. X. Lambris, J. D. Blatteis, C. M.
(2003).
Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential. Faseb Journal
17(7):C108.
|
||
Li, S. X. Lambris, J. D. Blatteis, C. M.
(2003).
Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential..
Faseb Journal
17(7):C108.
|
||
Madhavan, M. C., Kimura, Y., Call, M. K. Santiago, W. Tsonis, P. A. Lambris, J. D. Del Rio-Tsonis, K.
(2003).
Do complement molecules play a role in lens regeneration?.
Investigative Ophthalmology & Visual Science
44:U324.
|
||
Morikis, D. Mallik, B.and Lambris, J. D.
(2003).
Molecular dynamics simulations of the NMR structural ensemble of Compstatin: A first step towards dynamics-activity relations in rational drug design.
2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences
9:45.
|
||
Morikis, D.and Lambris, J. D.
(2003).
Immunophysics of the complement system: The role of electrostatic fields in C3d-CR2(SCR1/SCR2) association.
2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences
9:44.
|
||
Mullick, J. Bernet, J.Singh, A. K. Lambris, J. D. Sahu, A.
(2003).
Kaposi's sarcoma-associated herpesvirus open reading frame 4 protein(Kaposica) targets C3 and C4 to inactivate complement.
Molecular Immunology
40(2-4):175.
|
||
Ross, G. D. Hansen, R. D. Allendorf, D. J. Baran, J. T. Yan, J.Subbarao, K. Haribabu, B. Lambris, J. D.
(2003).
Tumor regression mediated by beta-glucans against iC3b-opsonized tumors requires CR3(+) neutrophils recruited via C5a and leukotriene B-4(LTB4).
Faseb Journal
17(7):C128.
|
||
Yamada, K. Miwa, T.Liu, J. N.Funk, C.Lambris, J. D. Nangaku, M. Song, W. C.
(2003).
Time-dependent involvement of complement and leukotriene pathways in a mouse model of renal ischemia reperfusion injury.
Journal of the American Society of Nephrology
14:565A.
|
||
Brekke, O. L., Fure, H. Christiansen, D.Lappegard, K. T. Fung, M.Lambris, J. D. Mollnes, T. E.
(2002).
Key role of the C5a receptor in Escherichia coli-induced oxidative burst and phagocytosis studied in a novel human whole blood model of inflammation.
International Immunopharmacology
2:1235.
|
||
Erdei, A. Laszlo, G.POlah, E.Prechi, J.Papp, K.Csomor, E.Argyropoulos, E. Franchini, S. Mastellos, D. Lambris, J. D.
(2002).
Monoclonal antibodies against mouse C3-fragments; A new repertoire of reagents targeting C3-mediated functions.
International Immunopharmacology
2:1327.
|
||
Fleming, S. D., Lambris, J. D., Shea-Donohue, T. Tsokos, G. C.
(2002).
The C5a fragment of C5 is critical for the mesenteric ischemia/reperfusion-induced local and remote organ injury.
Int.Immunopharmacol
2(9):1308.
|
||
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E.
(2002).
A critical role for complement C5 in antiphospholipid antibody-induced pregnancy loss.
Arthritis and Rheumatism
46(9):S219.
|
||
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E.
(2002).
Complement C5 activation mediates antiphospholipid antibody-induced pregnancy loss.
Int.Immunopharmacol
1239.
|
||
Kijowski, J. Reca, R.Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. Ratajczak, M. Z.
(2002).
Evidence that anaphylatoxin C3a cooperates with SDF-1 in homing/mobilization of hematopoietic stem/progenitors by priming CXCR4 responses to SDF-1.
Blood
100(11):108A.
|
||
Kimura, Y. Lambris, J. D. Tsonis, P. A. Del Rio-Tsonis, K.
(2002).
The role of compelement in newt lens and limb regeneration.
International Immunopharmacology
2:1364.
|
||
Lappegard, K. T., Hvassing, T., Fung, M.Lambris, J. D. Riesenfeld, J. Mollnes, T. E.
(2002).
Attenuation of artificial surface-induced leukocyte activation by blocking C2, factor D, C5 and C5a receptor.
International Immunopharmacology
2:1308.
|
||
Miwa, T. Zhou, L.Hilliard, B. Lambris, J. D. Molina, H.and Song, W. C.
(2002).
Differential roles of DAF, Crry and CD59 in regulating alternative and classical pathway complement activation on murine erythrocytes.
International Immunopharmacology
2:1223.
|
||
Morikis, D. Soulika, A. M Lambris, J. D.
(2002).
Rational design of a complement inhibitor targeting C3 using NMR and combinatorial approaches.
Biochemical Society Transactions
30:A100.
|
||
Morikis, D. Soulika, A. M Lambris, J. D.
(2002).
Structural-activity based design of compstatin using analogs NMR and combinatorial approaches.
International Immunopharmacology
2:1229-1230.
|
||
Nacewicz, B. Liu, F.Sewell, D.Lambris, J. D. Sandor, M.and Fabry, Z.
(2002).
The role of complement in traumatic injury of the brain.
Faseb Journal
16(4):A682.
|
||
Ratajczak, M. Z., Reca, R.Majka, M., Kijowski, J. Mastellos, D.
(2002).
The role of a newly identified heterologous crosstalk between G-protein coupled seven-transmembrane span receptors: Chemokine receptor CXCR4 and complement C3aR in human hemato-lymphopoiesis and innate immunity.
International Immunopharmacology
2: 1351.
|
||
Reca, R. Majka, M.Janowska-Wieczorek, A. Lambris, J. Ratajczak, M.
(2002).
A new unexpected role of the third complement component (C3a)-C3a receptor(C3aR) axis in regulating human hematopoiesis.
Experimental Hematology
30(6):59.
|
||
Reca, R. Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z.
(2002).
Normal human CD34 hematopoietic progenitors, myeloblasts, megakaryoblasts and erythroblasts express functional complement C3a receptor that sensitizes their chemotactic responses to SDF-1.
Blood
100(11):148B.
|
||
Spruce, L. Argyropoulos, E. Mastellos, D. Sfyoera, G. Lambris, J. D.
(2002).
Chemical synthesis of small complement proteins and protein modules.
International Immunopharmacology
2:1320-1321.
|
||
Strey, C. W. Markiewski, M. M. Mastellos, D. Tudoran, R. Greenbaum, L. Lambris, J.
(2002).
The role of complement in liver regeneration.
International Immunopharmacology
2:1249.
|
||
Strey, C. W. Spellman, d Markiewski, M. M. Lambris, J. D.
(2002).
Proteomic analysis of mouse C3 deficiency and liver partial hepatectomy.
International Immunopharmacology
2:1241.
|
||
Wyss-Coray, T., Lin, A. H. T., Yan, F. R.Lambris, J. Alexander, J. J. Quigg, R. J. Masliah, E.
(2002).
Overproduction of complement inhibitor Crry increases Alzheimer's-type pathology in transgenic mice.
Neurobiology of Aging
23: S221.
|
||
Zetoune, F. S., Huber-Lang, M. S.Riedemann, N. C. Sarma, V.Neff, T.Younkin, E. M. Laudes, I. J. McGuire, S. R. Guo, R. F.Lambris, J. D. Spruce, L.Mastellos, D. Ward, P. A.
(2002
).
Role for C5a in mouse peritoneal sepsis.
Faseb Journal16
(4):A592.
|
||
Christiansen, D., Fure, H.Bergseth, G., Lambris, J. D. Mollnes, T. E.
(2001).
E-coli-induced upregulation of granulocyte CR3 contributes to oxidative burst and is totally C5a receptor dependent.
Molecular Immunology
38(2-3):83.
|
||
Fabry, Z. Nazewicz, B. Liu, F.Sewell, D.Lambris, J. D. Sandor, M.
(2001).
The role of complement in acute traumatic injury of the brain.
International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October
|
||
Fleming, S. D., Lambris, J. D., Shea-Donohue, T. Tsokos, G. C.
(2001).
C5a in responsible for the mesenteric ischemia/reperfusion-induced local and remote organ injury.
International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October
|
||
Fure, H. Christiansen, D. Brekke, O. L. Bergseth, G. Lappegard, K. T. Lambris, J. D. Fung, M.and Mollnes, T. E.
(2001).
E-coli-induced oxidative burst is complement dependent and can be abolished by different modes of complement inhibition.
Molecular Immunology
38(2-3): 90-91.
|
||
Kijowski, J. Majka, M.Reca, R.Rozmyslowicz, T. Conover, D. O. Murphy, S. L. Janowska-Wieczorek, A. Gaulton, G. N. Lambris, J. Ratajczak, M. Z.
(2001).
The role of newly-identified heterologous crosstalk between G-protein coupled chemokine and complement seven transmembrane span receptors in human thymopoiesis.
Blood
98(11):821A.
|
||
Lambris, J. D., Del Rio-Tsonis, K.Franchini, S. Kimura, Y.Majka, M.Markiewski, M. M. Mastellos, D. Ratajczak, M. Z. Reca, R.Strey, C. W. Tsonis, P. A.
(2001).
The role of complement in developmental processes.
International Workshop on Complement Associated Diseases, Santorini, Greece,October
|
||
Lappegard, K. T., Bergseth, G., Lambris, J. D. Riesenfeld, J. Mollnes, T. E.
(2001).
Studies on the relationship between complement and leukocyte activation in blood circulated in uncoated and heparin coated PVC tubing.
Molecular Immunology
38(2-3):105.
|
||
Morikis, D. Soulika, A. M Roy, M.Troganis, A. Jennings, P. A. Tsokos, G.and Lambris, J. D.
(2001).
Rational design of a complement inhibitor targeting C3.
International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October
|
||
Reca, R. Majka, M.Mastellos, D. Zhao, D. L. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z.
(2001).
New unexpected stimulatory effects of complement proteins on human hematopoiesis: Evidence for crosstalk between G-protein-coupled C3a complement receptor(C3aR) and alpha-chemokine SDF-1 receptor(CXCR4).
Blood
98(11):64A.
|
||
Solvik, U. O., Haraldsen, G., Fiane, A. E. Boretti, E. Lambris, J. D. Fung, M.Thorsby, E. Mollnes, T. E.
(2001).
Human serum-induced E-selectin expression on porcine aortic endothelial cells is totally complement mediated: evidence for a role of complement in delayed xenograft rejection.
Xenotransplantation
8:120.
|
||
Ward, P. Huber-Lang, M. S. Reidemann, N. Spruce, L.Mastellos, D. Lambris, J. D.
(2001).
C5a in inflammatory responses: just right or too much?.
International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October
|
||
Franchini, S., Zarkadis, I. K.Sfyroera, G. Sahu, A.and Lambris, J. D.
(2000).
Cloning and purification of the rainbow trout fifth component of complement(C5).
Immunopharmacology
49:13.
|
||
Friedman, H. M., Saldanha, C., Wang, L. Y. Jiang, M.Grippi, K.Lambris, J. D. Lubinski, J.
(2000).
Herpes simplex virus immune evasio.
Clinical Infectious Diseases
31(1):316.
|
||
Guthridge, J., Rakstang, J, Young, KHinshelwood, J. Sarrias, M. R. Moore, W. T. Perkins, S. J. Overduin, M. Lambris, J. D. Karp, D.Hannan, J.and Holers, M.
(2000).
CR2/CD21 SCR1,2 domain ligand binding, physical properties and structural analysis.
Immunopharmacology
49: 46.
|
||
Guthridge, J., Younf, K. , Gipson, M.Hinshelwood, J. Sarrias, M. R. Lambris, J. D. Perkins, S. J. Holers, M.
(2000).
Novel inhibitory monoclonal antibodies to human CR2/CD21 ligand binding domains.
Immunopharmacology
49:69.
|
||
Lambris, J. D., Sahu, A., Soulika, A. M, Morikis, D. Moore, W. T. Spruce, L.and Sarrias, M. R.
(2000).
Compstatin: Structure-activity relationship, biotransformation, in vivo studies, and therapeutic potential.
Innate Immunity Workshop, Santorini, Greece
|
||
Lambris, J. D., Zarkadis, I. K.Franchini, S. Kimura, Y.Sarrias, M. R. Sfyroera, G. Moore, W. T. Sahu, A.
(2000).
Evolution and diversity of the complement system.
Innate Immunity Workshop, Santorini, Greece
|
||
Lambris, J. D., Zarkadis, I. K.Sarrias, M. R. Franchini, S. Sfyroera, G. Sahu, A.
(2000).
Structure and fuctions of trout complement proteins. Dev.Comp.
Immunology
24:23.
|
||
Mastellos, D., papadimitriou, SFranchini, S. Tsonis, P. A. Lambris, J. D.
(2000).
A role of Complement component C5 in liver regeneration.
Immunopharmacology
49:8.
|
||
Mollnes, T. E., Brekke, O. L., Koehl, J.Bergseth, G. Christiansen, D. Fure, H.Lappegard, K. T. Videm, V.Sahu, A.and Lambris, J. D.
(2000).
Inhibition of endotoxin-induced oxidative burst by the C3 binding peptide compstatin in a novel whole blood model of inflammation.
Immunopharmacology
49:62.
|
||
Moore, W. T.and Lambris, J. D.
(2000).
Proteomic analysis of C3 and its fragments.
Immunopharmacology
49:43.
|
||
Sahu, A. Soulika, A. M Morikis, D. Spruce, L.Moore, W. T. Lambris, J. D.
(2000).
Kinetics and proposed mechanism of binding of the complement inhibitor Compstatin.
Immunopharmacology
49:53.
|
||
Song, W. C. Scalia, R.Miwa, T.Lambris, J. D. Lefer, A. M.
(2000).
Dificiency of decayaccelerating factor(DAF) attenuates leukocyte-endothelium interation induced by hemorrhage and reinfusion.
Immunopharmacology
49:24.
|
||
Soulika, A. M, Khan, T.Hattori, F. W, Bowen, B. A Richardson, C. E Hack, C. E. Sahu, A.Edmunds, L. H Lambris, J. D.
(2000).
Inhibition of heparin/protamine complex-induced complement activation by Compastatin in baboons.
Immunopharmacology
49:62.
|
||
Zarkadis, I. K., Sfyoera, G., Kimura, Y.Franchini, S. Sahu, A.Moore, W. T. Lambris, J. D.
(2000).
Characterization of a factor H like molecules in rainbow trout.
Innate Immunity Workshop, Santorini, Greece
|
||
Zarkadis, I. K., Sfyroera, G., Franchini, S. Sahu, A.and Lambris, J. D.
(2000).
Characterization of factor H-like molecules in rainbow trout.
Dev.Comp.Immunol
24:13.
|
||
Irani, V. R.and Lambris, J. D.
(1999).
Studies on the interaction of C3dg with CR2.
Faseb Journal13
(4):A282.
|
||
Lambris,J.D. and Volanakis,J.E.
(1999).
Special Issue - Papers presented at the XVIIth International Complement Workshop - Rhodes, Greece - 11-16 October 1998 - Preface.
Immunopharmacology
42 (1-3):IX.
|
||
Noorchashm, H., Moore, D. J., Lieu, Y. K., Noorchashm, N., Schlachterman, A., Song, H. K., Lambris, J. D., Barker, C. F., and Naji, A.
(1999).
Contribution of the innate immune system to autoimmune diabetes: A role for the CR1/CR2 complement receptors.
Cellular Immunology
198(2):143.
|
||
Friedman,H.M., Wang,L., Nagashunmugam,T., Lambris,J.D., Pangburn,M.K., Sahu,A., Soulika,A., Wetsel,R.A., Colten,H., Eisenberg,R.J., Cohen,G.H. and Lubinski,J.
(1998).
HSV-1 glycoprotein gC complement regulatory domains involved in virulence.
Molecular Immunology
35 (6-7):348.
|
||
Lambris,J.D. and Volanakis,J.E.
(1998).
Abstracts of the XVII international complement workshop - Preface.
Molecular Immunology
35 (6-7):329.
|
||
Mollnes,T.E., Fiane,A.E., Videm,V., Sahu,A., Hovig,T., Mellbye,O.J., Hogasen,J., Spruce,L., Moore,W. and Lambris,J.D.
(1998).
Attenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by a peptide based C3 inhibitor.
Molecular Immunology
35(6-7):372.
|
||
Moore,W.T. and Lambris,J.D.
(1998).
Mass spectrometric analysis of the activation and expression products of the third component of complement (C3).
Molecular Immunology
35(6-7):373.
|
||
Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D.(1998). Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies. Arthritis and Rheumatism, 41(9):S172Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D.
(1998).
Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies.
Arthritis and Rheumatism
41(9):S172.
|
||
Myones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D.
(1998).
Complexes of factor H and phospholipids retain cofactor activity for C3 cleavage: Relationship to antiphospholipid antibodies.
Molecular Immunology
35 (6-7):373.
|
||
Nilsson, B., Larsson, R., Hong, J., Elgue, G., Ekdahl, K. N., Sahu, A., and Lambris, J. D.
(1998).
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.
Molecular Immunology
35(6-7):371.
|
||
Noorchashm,H., Lieu,Y.K., Wetsel,R., Colten,H.R., Barker,C.F., Soulika,A., Rostami,S.Y., Lambris,J.D. and Naji,A.
(1998).
B cell tolerance: A C3 dependent process.
Molecular Immunology
35(6-7):371.
|
||
Sahu, A., Isaacs, S. N., Soulika, A. M., and Lambris, J. D.
(1998).
Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-MEDIATED degradation of C3b to IC3b(1) inactivates the alternative complement pathway.
Molecular Immunology
35 (6-7):371.
|
||
Sahu,A., Morikis,D., Soulika,A.M., Spruce,L., Moore,W.T. and Lambris,J.D.
(1998).
Species specificity, structural functional analysis and biotransformation studies on Compstatin, a potent complement inhibitor.
Molecular Immunology
35 (6-7):371.
|
||
Sarrias,M.R., Zarkadis,I., Sunyer,J.O. and Lambris,J.D.
(1998).
Cloning of three trout C3 isoforms: Structural, functional, and phylogenetic analysis.
Molecular Immunology
35(6-7):370.
|
||
Solvik,U.O., Mollnes,T.E., Fiane,A.E., Vartdal,F., Endresen,M., Thorsby,E. and Lambris,J.D.
(1998).
Inhibition of complement and xenogeneic endothelial cell activation by Compstatin.
Molecular Immunology
35(6-7):372.
|
||
Soulika,A.M., Sahu,A. and Lambris,J.D.
(1998).
Localization of Compstatin binding site on C3.
Molecular Immunology
35(6-7):370.
|
||
Sun,X., Funk,C.D., Deng,C., Sahu,A., Lambris,J.D. and Song,W.C.
(1998).
Targeted disruption of the murine decay-accelerating factor(DAF) gene: Studies of erythrocytes reveal activity of DAF in regulating both autologous and heterologous complement activation.
Molecular Immunology
35 (6-7):372.
|
||
Sunyer,J.O. and Lambris,J.D.
(1998).
Evolution and diversity of the complement system of poikilothermic vertebrates.
Immunological Reviews
166:39-57.
|
||
Sunyer,J.O., Zarkadis,I., Sarrias,M.R., Hansen,J.D., Skiadas,A.P. and Lambris,J.D.
(1998).
Cloning, structure, and function of two rainbow trout Bf molecules: Both classical and alternative pathway activities require the presence of Bf-2.
Molecular Immunology
35(6-7):370.
|
||
Del Rio-Tsonis, K., Tsonis, P. A., Zarkadis, I. K. Tsangas, A. G. Lambris, J. D.
(1997).
Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles.
Molecular Immunology
34:372.
|
||
Friedman, H. M., Wang, L.Nagashunmugam, T.Lambris, J. D. Pangburn, M. K. Soulika, A. M Wetsel, R. A. Colten, H. R Eisenberg, R. J., Cohen, G. H. Lubinski, J.
(1997).
JSL-1 glycoprotein gC complement regulatory domains involved in virulence.
Molecular Immunology
34:348.
|
||
Gross, P. S. Sunyer, J. O. Lambris, J. D. Smith, L. C.
(1997).
The sea urchin complement C3 protein: Expression and function.
Dev.Comp.Immunol
21(2):150.
|
||
Lambris, J. D., Zarkadis, I. K., and Sunyer, J. O.
(1997).
Phylogeny and diversity of the third complement component C3.
7th ISDCI Congress.Develop.Comp.Immunol
21:143.
|
||
Mollnes, T. E., Fiane, A. E., Videm, V.Sahu, A.Hovig, T.Mellbye, O. J. Hogasen, K. Spruce, L.Moore, W. T. Lambris, J. D.
(1997).
Atytenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by peptide based C3 inhibitor.
Molecular Immunology
34:372.
|
||
Moore, W. T.and Lambris, J. D.
(1997).
Mass spectrometric analysis of the activation and expression products of the third component of complement(C3).
Molecular Immunology
34:373.
|
||
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Lambris, J. D. Peterson, L. H.
(1997).
Complexes of complement factor H and phospholipids retain cofactor activity for C3 cleavage and are capable of binding human monoclonal antiphospholipid antibodies.
Arthritis and Rheumatism
40(9):431.
|
||
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Peterson, L. H. Lambris, J. D.
(1997).
Complexes of factor H phospholipids retain cofactor activity for C3 Cleavage: relationship to antiphospholipid antibodies.
Molecular Immunology
34:373.
|
||
Nilsson, B. Larsson, R., Hong, J.Elgue, G.Nilsson-Ekdahl, K. Sahu, A.and Lambris, J. D.
(1997).
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal cilculation.
Molecular Immunology
34:371.
|
||
Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B. (1997). B cell tolerance: a C3 depedent process. Molecular Immunology, Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B.
(1997).
B cell tolerance: a C3 depedent process.
Molecular Immunology
34:371.
|
||
Sarrias, M. R., Zarkadis, I. K.Sunyer, J. O. Lambris, J. D.
(1997).
Cloning of three trout C3 isoforms: structural, functional, and phylogenetic analysis.
Molecular Immunology
34:370.
|
||
Solvik, U. O., Mollnes, T. E., Fiane, A. E. Vartdal, A. E. Endresen, M. Thorsby, E. Lambris, J. D.
(1997).
Inhibition of complement and xenogeneic endothelial cell activation by compstatin.
Molecular Immunology
34:372.
|
||
Soulika, A. M, Sahu, A. and Lambris, J. D.
(1997).
Localization of compstatin binding site on C3.
Molecular Immunology
34:370.
|
||
Sunyer, J. O., Zarkadis, I. K., and Lambris, J. D.
(1997).
Structural and functional characterization of B/C2 complement molecules in teleost fish.
Develop.Compar.Immunol
21(2):147.
|
||
Sunyer, J. O., Zarkadis, I. K.Sarrias, M. R. Hansen, R. D. Skiadas, A. P Lambris, J. D.
(1997).
Clining, structure and function of two rainbow trout Bf molecules: both classical and alternative pathway activities require the presence of Bf-2.
Molecular Immunology
34(370).
|
||
Tolnay, M. Lambris, J. D. Tsokos, G. C.
(1997).
An inducible heterogeneous nuclear ribonucleoprotein which functions as a DNA-binding transactivator.
Faseb Journal
11(9):A943.
|
||
Al-Sharif, W., Sunyer, J. O., Lambris, J. D. Smith, L. C.
(1997).
Characterization of the cDNA encoding a protein homologous to the mammalian complement component C3 which is expressed in sea urchin coelomocytes.
7th ISDCI Congress.Develop.Comp.Immunol
21:147.
|
||
Fisk, B. Dague, B.Seifert, W. E. Lambris, J. D. Papayannopoulos, I. Kudelka, A. Wharton, J. T. Ioannides, C. G.
(1996).
Ovarian cytotoxic T lymphocytes can recognize common peptides presented by HLA-A2+ tumors.
Joint Meeting of the American Society for Biochemistry and Molecular Biology, the American Society for Investigative Pathology andthe American Association of Immunologists, New Orleans, Louisiana, USA
10(6): 2707.
|
||
Friedman, H. M., Wang, L.Burger, R., Lambris, J. D. Eisenberg, R. J. Cohen, G. H. Lubinski, J.
(1996).
The role of Herpes Simplex Virus type 1 glycoprotein C, a C3b binding protein, in pathogenesis.
XVI International Complement Workshop Mol.Immunol
33:63.
|
||
Friedman, H. M., Wang, L.Fishman, N. O., Lambris, J. Eisenberg, R. J. Cohen, G. H. Pangburn, M. K. Lubinski, J.
(1996).
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
Journal of Investigative Medicine
44(3):A218.
|
||
Sahu, A. Isaacs, S. N. Lambris, J. D.
(1996).
Modulation of complement by recombinant vaccinia virus complement control protein.
XVI International Complement Workshop Mol.Immunol
33:61.
|
||
Sahu, A. Kay, B. K.and Lambris, J. D.
(1996).
Inhibition of human complement bya C3 binding peptide isolated from a phage-displayed random peptide library.
XVI International Complement Workshop Mol.Immunol
33:61.
|
||
Sunyer, J. O., Zarkadis, I. K.Sahu, A.and Lambris, J. D.
(1996).
Multiple forms of complement C3 in a tetraploid ad a diploid teleost fish, that differ in binding to complement activators.
XVI International Complement Workshop Mol.Immunol
33:61.
|
||
Tolnay, M.and Lambris, J. D.
(1996).
Purification and characterization of a nuclear protein and binds to a CRE-like motif in the promoter region of the complement receptor-2(CR2) gene.
Joint Meeting of the American Society for Biochemistry and Molecular Biology, The american Society for Investigatinve Pathology and the American Association of Immunologists, New Orleans, Louisiana,USA, June 2-6.FASEB Journal
10(6):A1445.
|
||
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I.
(1995).
Activation of the Complement Cascade by A Putative B-Cell Superantigen.
Journal of Allergy and Clinical Immunology
95(1):177.
|
||
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I.
(1995).
B-Cell Superantigen-Mediated Complement Activation in Mouse and Man.
Faseb Journal
9(3):A518.
|
||
Lambris, J. D., Mavroidis, M., and Sunyer, J. O.
(1995).
Isolation, primary structure and evolution of chicken C3 and evidence for a new member of thea2-M family.
FASEB J
9(3):A490.
|
||
Tolnay, M. Lambris, J. D. Smallridge, R. C. Tsokos, G. C.
(1995).
Transcriptional Control of the Complement Receptor-2 Gene by and Inducible Nuclear-Protein That Binds to A Camp Regulatory Element-Like Motif in the Promoter Region of the Gene.
Arthritis and Rheumatism
38(9):27.
|
||
Tolnay, M. Lambris, J. D. Tsokos, G. C.
(1995).
Regulation of Complement Receptor-2(Cr-2) Expression in Human B-Lymphoblastoid Cell(Blc) Lines.
Faseb Journal
9(3):A212.
|
||
Lambris, J. D. and Sunyer, J. O.
(1994).
Structural and functional analysis of a third isoform of trout third component of complement.
12th European Immunology Meeting, Barcelona, SpainJune
|
||
Lambris, J. D., Lao, Z.Kostavasili, I., and Wang, Y.
(1994).
Contribution of residues 727-768 of Hu C3 to its interaction with Hu CR1, B, and H.
Vth European Meeting on Complement in Human diseases.Les diablerets, Switzerland, September
|
||
Rux, A. H. Lambris, J. D. Wang, Y.Moore, W. T. Abrams, W. R Friedman, H. M. Cohen, G. H. Eisenberg, R. J.
(1994).
Disulfide bond analysis of trancated HSV gC from a baculovirus expression system.
In Abstracts of the 19th Herpesvirus Workshop, Vanvouver, BC
|
||
Tsoukas, C. D., Todd, S. C., and Lambris, J. D.
(1994).
Epstein-Barr-Virus Induces Proliferation of Human Thymocytes in A Mhc Class Ii-Dependent Fashion.
Journal of Cellular Biochemistry
370.
|
||
Hedrick, J. A., Lao, Z.Du, J.Lambris, J. D., and Tsoukas, C. D.
(1993).
Characterization of a novel EBV/C3 receptor.
Mol.Immunol
30:15.
|
||
Kostavasili, I., Peng, C.Hung, S. L., Wang, Y.Friedman, H. M. Eisenberg, R. Cohen, G. H. Lambris, J. D.
(1993).
Mapping of HSV-1 and HSV-2 gC interaction sites in C3 and modulation of C3 functions.
Mol.Immunol
30:25.
|
||
Lambris, J. D.
(1993).
Phylogenic analysis of C3.
American Associaton for Immunologists, Denver, Co.:May 22
|
||
Lambris, J. D., Lao, Z.Mavroidis, M., Pang, J.Pappas, J.Wang, Y.and Manzone, H.
(1993).
Phylogenic of the third component of complement and conservation of C3-ligand interations.
Primodial Immunity Conference Swope Center
|
||
Lambris, J. D., Mavroidis, M., Lao, Z.Pappas, J.Wang, Y.and Suner, O.
(1993).
Clonning of trout, chicken, and xenopus gilli C3: conservation of functional sites in the C3 from different species.
Mol.Immunol
30:27.
|
||
Hung, S. L. Peng, C.Friedman, H. M. Lambris, J. D. Huemer, H. P. Eisenberg, R. J. Cohen, G. H.
(1992).
The interaction of HSV gC with the complement system.
17th International Herpesvirus Workshop
|
||
Lambris, J. D., Zhege, L., Wang, Y.Manzone, H. Pang, J.Schwager, J. Mavroidis, M. Alsenz, J.
(1992).
Evolution of C3-Ligand Interactions.
Faseb Journal
6(4):A1453.
|
||
Sinha, S. K. Speiser, C. L. Hedrick, J. A. Escobar, S. Lambris, J. D. Tsoukas, C. D.
(1992).
Characterization of the Ebv/C3 Receptor on Human Lymphocytes-T.
Faseb Journal
6(4): A1451.
|
||
Hasty, L. A. Lessey, B. A. Pruksananonda, S. Lambris, J. D. Lyttle, C. R.
(1991).
The hormonal regulation of complement components throughout the menstrual cycle.
Annual Meeting of the Society for Gynecologic Investigation
|
||
Hedrick, J. A. Watry, D.Speiser, C. O' Donneli, P. Lambris, J. D. Tsoukas, C. D.
(1991).
Epstein-Barr virus-T lymphocyte interaction via a novel receptor.
FASEB J
5(5):A1340.
|
||
Huemer, H. P., Lambris, J. D., Lacher, C.Enquist, L. Babiuk, L.Eisenberg, R. J. Cohen, G. H. Friedman, H. M.
(1991).
Binding of complement component C3 to HSV-1 gC and gc homologous of PRV and BHV-1.
16th International Herpesvirus Workshop, Asilomar, CA
|
||
Pruksananonda, S., Caltalbiano, S.Lambris, J. D. Lyttle, C. R.
(1991).
Hormonal regulation of rat uterine C3 and factor B.
Complement and Inflammation
8:213.
|
||
Alsenz, J. Becherer, D., Esparza, I. Daoudaki, M. Avila, D.Oppermann, S. Lambris, J. D.
(1989).
Structure and Function Analysis of C3 from Different Species.
Complement and Inflammation
6:307.
|
||
Becherer, J. D., Alsenz, J. A., Hack, C. E. Drakopoulou, E. Lambris, J. D.
(1989).
Identification of common binding domains in C3b for members of the complement family of C3b-binding proteins.
Complement and Inflammation
6:313.
|
||
Esparza, I. Vilbois, F., Becherer, J. D. Lambris, J. D.
(1989).
Multiple sites of interaction in C3 for CR2/EBV-receptor: functional implications.
Complement and Inflammation
6:334.
|
||
Huemer, H. P., Burger, R., Garred, P.Cohen, G.Eisenberg, R. Friedman, H. Esparza.I.Dierich, M. P. Lambris, J. D.
(1989).
The interaction sites in C3b for HSV-1 gC and factor H are related.
Complement and Inflammation
6:348.
|
||
Myones, B. L., Avila, D. , Lachmann, P. J. Lambris, J. D.
(1989).
Lacalization of the epitopes recognized by anti-C3dg(clone 9) monoclonal antibody using synthetic peptides.
Complement and Inflammation
6:373.
|
||
Nilsson, B. Grossberger, D. Nilsson-Ekdahl, K. Riegert, P. Becherer, J. D. Nilsson, U. R. Lambris, J. D.
(1989).
Localization of neoantigenic epitopes in bound C3 fragments.
Complement and Inflammation
6:181.
|
||
Nilsson-Ekdahl, K., Nilsson, B., Becherer, J. D. Nilsson, U. R. Lambris, J. D.
(1989).
Further studies on the degradation of complement factor C3 by factor I. Inhibition of factor I with DFP.
Complement and Inflammation
6:332.
|
||
Tsokos, G. Lambris, J. D. Finkelman, F. D. Anastasiou, E. D. June, C. H.
(1989).
Monovalent ligants of complement receptor 2 inhibit while polyvalent ligants enhance anti-immunoglobulin induced human B cell intracytoplasmic free calcium concentration.
Complement and Inflammation
6:407.
|
||
Wörner, I. Burger, R.and Lambris, J. D.
(1989).
Localization and functional characterization of epitopes on alpha and beta chains of C3.
Complement and Inflammation
6:416.
|
||
Alsenz, J.and Lambris, J. D.
(1988).
Modulation of factor H(H) functional activities by monoclonal antibodies(MoAbs) to H.
Complement
5:202.
|
||
Bogen, B. Weiss, S.and Lambris, J. D
.
(1988).
B lymphoma cells process and present their surface Ig V-regions to MHC-restricted T cells.
Ninth European Immunology Meeting, Roma
|
||
Bogen, B.and Lambris, J. D.
(1988).
An eleven aminoacid long peptide activates idiotope-specific, I-E d restricted T cell clones.
International Immunology Meeting, Berlin
15:4.
|
||
Grossberger, D., Riegert, P., Becherer, J. D. Nilsson, B. Nilssonekdahl, K. Nilsson, U. R., and Lambris, J. D.
(1988).
Monoclonal Anti-C3 Antibodies Specific for Either Bound Or Fluid Phase C-3 - Mapping of Their Antigenic Sites in C-3 by the Use of Expression Minilibrary.
Faseb Journal
2(6):A1643.
|
||
Nilsson, B. Nilsson Ekdahl, K. Avila, D.Nilsson, U. R. Lambris, J. D.
(1988).
Monoclonal anti-C3 antibodies specific for bound iC3b: Mapping of the recognized epitopes on C3 by synthetic peptides.
Complement
5:206.
|
||
Huemer,H.P., Broker,M., Lambris,J. and Dierich,M.P.
(1988).
Hsv Type-1 Interaction with Human Complement-Binding Specifity of A Viral Pathogenicity Factor.
Immunobiology
178(1-2):63.
|
||
Becherer, D.and Lambris, J. D.
(1987).
Localization of C3b receptor binding domain in C3.
Complement
4:132.
|
||
Becherer, J. D., Daoudaki, M. E., and Lambris, J. D.
(1987).
Conservation of the C-3 Ligand-Binding Sites Within Different Species.
Federation Proceedings
46(3):771.
|
||
Daoudaki, M. E. and Lambris, J. D.
(1987).
The properdin binding site in C3 as delineated by synthetic peptides.
Complement
4:146.
|
||
Daoudaki, M. E., Becherer, J. D., and Lambris, J. D.
(1987).
Localization of the P and C5 binding sites on the third component of complement.
Fed.Proc
46:1024.
|
||
Lambris, J. D., Avila, D., and Becherer, J. D.
(1987).
Interaction of factor H with C3 :Involvement of two C3 sites in the H cofactor activity.
Complement
4:183.
|
||
Lambris, J. D., Becherer, J. D.Avila, D.and Müller-Eberhard, H. J.
(1986).
Localization of the factor H binding site on the third component of complement.
Immunobiology
173:493.
|
||
Fishelson, Z., Lambris, J. D., and Müller-Eberhard, H. J.
(1985).
Modulation of complement C3bBb activity and stability by monoclonal antibodies to Bb.
Complement
2:25.
|
||
Hirani, S. Lambris, J. D. Mullereberhard, H. J.
(1985).
Analysis of the Carbohydrate Moieties of the 3Rd Component of Human-Complement.
Federation Proceedings
44(4):989.
|
||
Lambris, J. D., Becherer, D., and Müller-Eberhard, H. J.
(1985).
Localization of the factor H binding site on complement C3.
Complement
2:48.
|
||
Lambris, J. D., Ganu, V. S., Hirani, S.and Mullereberhard, H. J.
(1985).
Mapping of the C3D Receptor(Cr2)-Binding Site and A Neoantigenic Site in the C3D Domain of the 3Rd Component of Complement.
Proceedings of the National Academy of Sciences of the United States of America
82(12):4235.
|
||
Lambris, J. D., Hirani, S., Ganu, V. S. Becherer, D. Müller-Eberhard, H. J.
(1985).
Localization of the complement C3d receptor binding site and monoclonal antibody 130 antigenic site on complement C3.
Fed.Proc
44:1531.
|
||
Tsokos, G. C. and Lambris, J. D.
(1985).
Modulation of Cyto-Toxic Responses by Complement - C3C3B and C3D Fragments Enhance Allogeneic Cell-Mediated Lympholysis.
Federation Proceedings
44(6):1877.
|
||
Aguado, M. T., Lambris, J. D., Tamerius, J. D. Dixon, F. J. Theofilopoulos, A. N.
(1984).
Use of anti-C3 monoclonal antibodies to detect C3-bearing immune complexes and complement activation.
Fed.Proc
43:1614.
|
||
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P.
(1984).
Structure-Function Relationship of Factor-H Investigated by Enzymatic Cleavages and Monoclonal Anti-H Antibodies.
Immunobiology
168(1-2):97.
|
||
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P.
(1984).
The C3b binding site and the cofactor activity is localized in the 38Kd trypsin fragment of factor H.
Fed.Proc
43:1447.
|
||
Lambris, J. D., Hirani, S., Ganu, V.and Müller-Eberhard, H. J.
(1984).
Molecular aspects of the complement C3 interaction with conglutinin complement receptor CR3 and complement receptor CR2.
Complement
1 :165.
|
||
Tsokos, G. C., Inghirami, G., Balow, J. E. Tsoukas, C. D. Lambris, J. D.
(1984).
Regulation of immunoglobulin secretion by human B cells in vitro by factor H.
Fed.Proc
43 :1763.
|
||
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P.
(1983).
Localization of Functionally Relevant Sites in Factor-H.
Immunobiology
165(3-4):236.
|
||
Alsenz, J. Lambris, J. Schulz, T. F. Dierich, M. P.
(1983).
Localization of the C3B-Binding Site in Factor-H.
Immunobiology
164(3-4):204.
|
||
Schulz, T. F., Rieber, P., Lambris, J. Riethmuller, G. Dierich, M. P.
(1983).
Antigenic Relationship Between the Membrane-Receptor for Factor-H, the Alpha-Chain of C-3, and A Leukocyte Surface-Antigen Defined by Monoclonal Antibody-M522.
Immunobiology
164(3-4):295.
|
||
Schulz, T. F., Scharfenberger, H.Rieber, P.Lambris, J. D. Riethmuller, G. Dierich, M. P.
(1983).
The Leukocyte Surface Antigen-M522, Antigenically Related to the H-Receptor and the Alpha-Chain of C-3, Is Involved in the Activation of Human-Monocytes and Neutrophils.
Immunobiology
165(3-4): 356.
|
||
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P.
(1983).
Involvement of Membrane-Associated Factor-H in the C3B-Receptor Function of Human Lymphocytes-B Investigated with Monoclonal-Antibodies Against Human Factor-H.
Immunobiology
164(3-4):296.
|
||
Scheiner,O., Schulz,T., Lambris,J., Schmid,H.U., Alsenz,J. and Dierich,M.P.
(1983).
Role of Membrane-Associated Factor-H in the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells.
Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene Series A-Medical Microbiology Infectious Diseases Virology Parasitology
253(4):439.
|
||
Lambris, J. D., Cohen, P. L., Dobson, N. J. Wheeler, P. W. Papamichail, M. Ross, G. D.
(1982).
Effect of Antibodies to Cr-2(C3D Receptors) on Lymphocyte-Activation.
Clinical Research
30(2):A514.
|
||
Lambris, J. D., Scheiner, O., Schulz, T. F. Dierich, M. P.
(1982).
Coupling of C3B to Erythrocytes by Disulfide Bond Formation - Preparation of Stable and Sensitive E-C3B for Hemolytic and Complement Receptor Assays.
Immunobiology
162(4-5): 383.
|
||
Lambris, J. D., Schulz, T. F., Schreiner, O. Dierich, M. P.
(1982).
Preparation of complement C3b coated erythrocytes for hemolytic and complement receptor assays by coupling complement C3b to activated thiol erythrocytes.
Immunobiology
163:203.
|
||
Macrae, E. K., Pryzwansky, K. B.Schwab, J. H. Lambris, J. D.
(1982).
Aggregation of Human-Leukocytes and Erythrocytes After Stimulation with Serum-Opsonized Streptococcal Cell-Wall.
Journal of Cell Biology
95(2):A13.
|
||
Ross, G. D.and Lambris, J. D.
(1982).
Identification of 3 Forms of Ic3B That Have Distinct Structures and Receptor-Binding Site Properties.
Molecular Immunology
19(11):1399.
|
||
Schreiner, O., Schulz, T., Lambris, J. Schmid, H. U. Alsenz, J.and Dierich, M. P.
(1982).
The Role of Membrane-Associated Factor-H for the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells.
Immunobiology
162(4-5):415.
|
||
Schulz, T. F., Alsenz, J., Scheiner, O. Lambris, J. D. Dierich, M. P.
(1982).
Use of monoclonal antibodies against factor H to investigate the role of factor H in complement C3b dependent rosette formation.
Immunobiology
162:421.
|
||
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P.
(1982).
Use of monoclonal antibodies against factor H to demonstrate the presence of factor H in lymphocyte membranes and to investigate its role in immunoadherence.
First International Workshop on Human Differentiation AntigensImmunobiology, Paris
|
||
Pryzwansky,K.B., Lambris,J.D., Schwab,J.H. and Macrae,E.K.
(1982).
Capping of Complement Receptors on Human-Neutrophils Induced by Opsonized Group A Streptococcal Cell-Walls.
Journal of Cell Biology
95(2):A437.
|
||
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P.
(1982).
Involvement of membrane associated factor H in complement C3b dependent rosette formation demonstrated by mono clonal antibodies against human factor H.
Immunobiology
163:207.
|
||
Dobson, N. J., Lambris, J. D., Bleau, S. A. Ross, G. D.
(1981).
Role of Human Neutrophil Complement Receptors and Beta-1H in the Release of Superoxide Anion.
Federation Proceedings
40(3):1014.
|
||
Hutt Fletcher, L. M.Fowler, E., Simmons, J. Feighay, R. Lambris, J. D. Ross, G. D.
(1981).
Characterization of Raji cell extract that binds the Epstein-Barr virus.
Int.Workshop on Herpes Virus
|
||
Lambris, J. D., Dobson, N. J., and Ross, G. D.
(1981).
Isolation of Lymphocyte Membrane Complement Receptor Type-2 (the C3D Receptor) and Preparation of Receptor-Specific Antibody.
Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences
78(3):1828.
|
||
Newman, S. L., Dobson, N. J., Lambris, J. D., Ross, G. D. Henson, P. M.
(1981).
Specificity and Function of Human Macrophage Complement Receptors for Different Fragments of C-3.
Federation Proceedings,
40(3):1017.
|
||
Lambris,J.D., Dobson,N.J., Dozier,M. and Ross,G.D.
(1981).
Antibody to the Idiotype of Anti-Beta-1H Has Specificity for Beta-1H Lymphocyte-B Membrane Beta-1H Receptors and C3B.
Federation Proceedings
40 (3):1013.
|
||
Hutt Fletcher, L. M.,Fowler, E., Feighny, R. J. Sullivan, B. Lambris, J. D. Ross, G. D.
(1980).
Epstein-Barr and C3d are bound by different components of cell membrane. Fifth Herpes Virus Workshop.
Cold Spring Harbor
|
||
Ross, G. D. Lambris, J. D. Dobson, N. J.
(1980).
B lymphocyte response to complement activators: release of endogenous C3b inactivator(C3bINA) following exposure to C5 convertase.
Abstracts 4th Int.Cong.Immunol.,Paris
|
||
Huber-Lang, M., Sarma, V., Younkin, E. M. McGuire, S. R. Lu, K. T.Neff, T.Guo, R. F.Gebhard, F. Lambris, J. D. Ward, P. A.
International Immunopharmacology.
Protective effects by C5aR antagonist(C5aRa) during experimental sepsis
2:1244.
|
||

